iSpecimen (ISPC)
(Delayed Data from NSDQ)
$5.23 USD
-0.01 (-0.19%)
Updated Oct 4, 2024 03:51 PM ET
After-Market: $5.29 +0.06 (1.15%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for iSpecimen Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 10 | 10 | 11 | 8 | 4 |
Cost Of Goods | 5 | 5 | 5 | 4 | 2 |
Gross Profit | 5 | 6 | 6 | 5 | 2 |
Selling & Adminstrative & Depr. & Amort Expenses | 16 | 16 | 12 | 7 | 6 |
Income After Depreciation & Amortization | -11 | -10 | -6 | -2 | -4 |
Non-Operating Income | 0 | 0 | -1 | 0 | 1 |
Interest Expense | 0 | 0 | 2 | 2 | 2 |
Pretax Income | -11 | -10 | -9 | -5 | -5 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -11 | -10 | -9 | -5 | -5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -11 | -10 | -9 | -5 | -5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -9 | -9 | -4 | -1 | -3 |
Depreciation & Amortization (Cash Flow) | 2 | 1 | 2 | 1 | 1 |
Income After Depreciation & Amortization | -11 | -10 | -6 | -2 | -4 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 0.45 | 0.44 | 0.21 | NA | NA |
Diluted EPS Before Non-Recurring Items | -24.60 | -23.20 | -41.80 | NA | NA |
Diluted Net EPS (GAAP) | -24.60 | -23.20 | -41.80 | -99.40 | NA |
Fiscal Year end for iSpecimen Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 2.86 | 2.29 | 2.58 | 2.78 | 1.63 |
Cost Of Goods | 1.42 | 1.00 | 1.43 | 1.39 | 0.85 |
Gross Profit | 1.44 | 1.29 | 1.15 | 1.39 | 0.77 |
SG&A, R&D, and Dept/Amort Expenses | 3.62 | 4.29 | 4.02 | 3.58 | 4.33 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.18 | -3.00 | -2.87 | -2.19 | -3.56 |
Non-Operating Income | 0.08 | 0.10 | -0.20 | 0.09 | 0.08 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -2.11 | -2.90 | -3.07 | -2.11 | -3.48 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.11 | -2.90 | -3.07 | -2.11 | -3.48 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.11 | -2.90 | -3.07 | -2.11 | -3.48 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 0.57 | 0.46 | 0.45 | 0.45 | 0.45 |
Diluted EPS Before Non-Recurring Items | -3.80 | -6.40 | -6.80 | -4.60 | -7.80 |
Diluted Net EPS (GAAP) | -3.80 | -6.40 | -6.80 | -4.60 | -7.80 |